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PURPOSE: To quantify the use of multiple and prolonged antibiotics and anti-infective drug therapy in clinical patients in a 144-
bed hospital.
METHODS: Adult patients (2,790 patients with 3,706 admissions over a period of 19 months) were investigated prospectively
regarding treatment with anti-infective agents. The mean age was 57.4 (range, 18.8 – 97 years), and 54.3% were females (2012).
RESULTS: Hospital stay was 5.5 (6.7 days (range, 2 – 226 days), with duration up to 10 days for 91.9% of the subjects. Antibiotics
or other agents were administered to 1,166 subjects (31.5%), 325 (8.8%) required assistance in the ICU, and a total of 141 (3.8%)
died. The association between anti-infective drug therapy and hospital mortality was statistically significant (P < .01) with a
strong linear correlation (r = 0.902, P = .014). The quantity of prescribed antimicrobial drugs, age, and need for ICU assistance
were independent variables for death by logistic regression analysis. The odds ratio for anti-infective drug therapy was 1.341
(1.043 to 1.725); for age, 1.042 ( 1.026 to 1.058); and for stay in the ICU, 11.226 ( 6.648 to 18.957).
CONCLUSIONS: 1) The use of large amounts of anti-infective drug therapy was associated with higher hospital mortality
according to both univariate and logistic regression analysis; 2) The adverse influence was less marked than that of hospitalization
in ICU but of a similar order of magnitude as age; 3) Further studies should elucidate whether infectious foci, noninfectious
morbidity, or drug effects underlie this undesirable concurrence .
KEYWORDS: Antibiotics. Antimicrobial therapy. Antibiotic association. Multiple antibiotics. Hospital prognosis. Hospital
mortality.
INTRODUCTION
Prognostic determinators are valuable tools for assess-
ing outcome in various disease contexts. When included
in validated protocols, they may help in the allocation of
scarce resources and manpower, in the elimination of re-
dundant tests or therapies, and in auditing clinical results,
thus helping in cost containment and increased efficacy of
hospital care. Scoring systems also provide a useful means
of comparing results of different institutions.1
Various scoring systems have been developed in efforts
to quantify the risk for a patient from a disease or an in-
tervention. The majority address critical illness, trauma,
pancreatitis, surgery, and other life-threatening situations,
but protocols for nonsurgical hospitalized patients are avail-
able as well.2
In surgical candidates, the American Society of
Anesthesiology classification (ASA)3 is probably the sim-
plest and most traditional assessment, whereas few scor-
ing methods match the popularity of the APACHE series
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in intensive care units.4-5 Trauma score or TRISS are a
mainstay of initial evaluation in emergency units along with
the Glasgow coma score,6–8 but multiple other
standardizations exist, based on physiologic,9,10 nutri-
tional,11,12 septic,13 and other14 criteria.
Single measurements have also been consistently en-
dorsed in infections, cardiovascular diseases, hepato-pan-
creatic conditions, major surgery, and various clinical con-
texts.15–22 One rather unusual study23 reported that the sur-
geon’s “gut feeling” was also a good indicator of subse-
quent outcome in the case of major procedures. A recent
report evaluated blood transfusion effects on mixed venous
oxygen saturation and lactate levels in patients with SIRS/
sepsis.24
Prognostic equations based on monitoring interventions,
therapeutic requirements, and need for nursing care include
the Therapeutic Intervention Scoring System (TISS) and the
simplified TISS-28,25 the Nurses Intervention Classification
(NIC),26 and others.27
Use of antibiotic or multiple anti-infective agents in clini-
cal patients is not part of any known prognostic marker, nei-
ther singly nor in association with other indicators. Yet, in-
fectious diseases alone, or with comorbidities that might re-
quire such prescriptions are not uncommonly observed in
hospitalized subjects, and aggressive prescriptions could be
a marker of poor outcome. Therefore, a prospective investi-
gation was designed to evaluate the impact of such inter-
vention on hospital mortality.
METHODS
Setting: The study was performed in a 144-bed private
general hospital. Most adult specialties were represented,
including AIDS, but with frequencies for trauma, burns,
chronic renal failure, and transplanted subjects was low.
Study design – A prospective controlled cohort obser-
vational study involving clinical wards of the entire insti-
tution was carried out. During 19 months, between July
2002 and December 2003, the use of all prescribed antibi-
otics and anti-infective agents in nonsurgical services was
recorded, and compared with hospital mortality.
Experimental hypothesis: Use of multiple or prolonged
anti-infective drug therapy is associated with hospital mor-
tality.
AIMS: 1) To quantify the anti-infective agents used in
hospitalized patients 2) To correlate such use, and espe-
cially the use of multiple agents or prolonged use with the
hospital mortality rate.
Inclusion criteria:
• Age >18 years, males or females
• General wards or intensive care unit
• Prophylactic or therapeutic indication
• Single or multiple drugs
• Exclusion criteria
• Surgical cases
• Death or discharge before 48 hours
Stratification: Patients were stratified into Group I (n =
1,166) and controls (Group II, n = 2,540). The test group
encompassed all clinical cases admitted to the hospital
wards during the study period who received 1 or more anti-
infective drugs. Controls were similar patients hospitalized
at the same period who in the view of the responsible
internist did not require antimicrobial therapy.
Clinical methods: The following variables were
analyzed: age, gender, total length of hospital admission,
hospitalization in the intensive care unit (ICU), number of
prescriptions for anti-infective agents, duration of anti-in-
fective therapy, mortality.
Study protocol: Patients were recruited at admission and
followed till discharge or death. In case of multiple admis-
sions, each hospitalization was considered a new case, and
all statistics refer to admissions, not to individuals, unless
stated otherwise.
For the purposes of this investigation anti-infective
agents included antibiotics as well as antifungal and anti-
viral substances. If more than 1 product was used during
hospitalization, either in association or sequentially, a mul-
tiple-agent situation was documented.
Ethical procedures: This study was approved by the
Ethical Committee of the Hospital.
Statistical tests: Values are shown as mean ± SD. Sta-
tistical analysis was done using the SPSS software pack-
age, version 10.0. Variables with a normal distribution, con-
firmed by the Kolmogorov-Smirnov test, such as age, hos-
pitalization period, and number of drugs used, were com-
pared using 2-tailed analysis of variance (ANOVA) con-
firmed by Tuckey post-hoc test, as well as by the Student
t test. Discrete variables (gender, admittance to the ICU,
and mortality) were investigated using the chi-square test.
Linear regression analysis (Pearson) was applied to iden-
tify relevant clinical correlations, and correlation between
antibiotic administration and death was determined by lo-
gistic regression analysis. A significance level of 5% (P <
.05) was adopted in all circumstances.
RESULTS
A total of of 2,790 patients with 3,706 admissions was
studied. Hospital stay was 5.5 ± 6.7 days (range, 2 – 226),
with duration up to 10 days in 91,9% of the subjects. Age
was 57.4 ± 18.8 years (range, 20 – 97), and 54.3% were
females (2012).
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Antibiotics or other agents were administered to 1,166 ad-
mitted patients (31.5%); 325 (8.8%) required assistance in the
ICU, and a total of 141 (3.8%) died. Groups I and II had simi-
lar age (57.8 ± 20.1 versus 56.7 ± 18.2 years, P = .136) and
gender distribution (54.1% versus 54.4%, P = .886).
Among those prescribed antibiotics and related drugs,
the great majority received a single anti-infective agent, but
as many as 5 or more such drugs were occasionally neces-
sary (Table 1). Age distribution according to number of
anti-infective agents administered is shown in Table 2.
There was no difference in gender among the subgroups
in Table 2, but the age of the groups was different (P =
.002, ANOVA). The Tuckey test revealed that this differ-
ence was due to the difference between subgroups 1 and
2, patients in subgroup 2 (2 antimicrobial drugs) being sig-
nificantly older than those in subgroup 1; other groups were
small and did not permit adequate analysis. Nevertheless,
no progressive age pattern could be identified for increas-
ing numbers of prescriptions, as those requiring more sub-
stances were not systematically older or younger than those
taking one agent alone.
An association between number of anti-infective agents
and hospital death was found to be significant (Table 3).
This association is illustrated in Figure 1, representing the
regression analysis for anti-infective drug therapy versus
death frequency. The correlation was very strong (Pearson
coefficient, r = 0.902, P = .014; adjusted determination co-
efficient r2 = 0.766).
Hospitalization in the ICU did not correlate with in-
creased numbers of prescribed anti-infective drugs (P = .731).
Among the 1,166 patients that were antibiotic managed, 105
were admitted to intensive care, and corrrepondingly, 220
of the 2,540 patients who remained free from anti-infective
drug therapy were also admitted to the ICU (9.0% versus
8.7%, NS). Nevertheless, ICU cases had significantly higher
mortality (18.8% versus 2.4% mortality, P < .01).
Surviving patients were younger (56.6 ± 18.8 years) than
those who died (69.2 ± 15.4, P < .01), but gender was not
Table 1 - Anti-infective drugs in the treated population (Test
group, n = 1166)
Number of drugs Patients Percentage
1 849 72.8%
2 231 19.8%
3 54  4.6%
4 14  1.2%
5 or more 18  1.5%
Table 3 - Hospital mortality according to number of anti-infective agents (All patients, n = 3,706)
Number of antimicrobial drugs Patients Mortality (absolute) Mortality (%) Significance*
Control Group
0 2,540 54 2.1%
Test group
1 849 52 6.1%
2 231 19 8.2% P < .01
3 54 7 13.0%
4 14 2 14.3%
5 or more 18 7 33.3%
(*) Univariate analysis, in comparison with controls
Table 2 - Age distribution according to number of anti-
infective agents administered (Test group, n = 1166)
Number of drugs Patients Age Confidence interval
1 849 59.0 ± 19.9 57.7 – 60.4*
2 231 53.5 ± 20.1 50.9 – 56.1*
3 54 56.8 ± 19.7 51.4 – 62.2
4 14 48.8 ± 17.1 38.9 – 58.7
5 or more 18 62.4 ± 22.3 51.3 – 73.6
(*) Age difference between 1 and 2 anti-infective agents administered, P
= .002.
Figure 1 - Linear correlation line of number of anti-infective agents versus
fatal outcome (all patients, n = 3706)
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different (P = .259). Their hospitalization period was also
shorter, as would be expected (5.3 ± 6.5 versus 10.7 ± 10.9
days, P < .01), in parallel with their days on antibiotic/anti-
infective drugs ( 2.3 ± 5.6 versus 7.9 ± 12.3 days, P < .001).
Logistic regression analysis of hospital mortality in the
present model, based on the variables selected by univariate
correlation, revealed that anti-infective drug load measured
by 2 different criteria, along with age and hospitalization
in the ICU, were significant and independent factors. Those
criteria as previously explained were number of days on
anti-infective drugs and number of administered anti-infec-
tive drugs, and they were closely related measurements (r
= 0.738, P < .01). Consequently, it was appropiate to use
either one or the other, but not both in the same regression
equation. Odds ratio pointed out anti-infective drug load
and age (34.1% and 4.2% increased probability of mortal-
ity, respectively) as moderate prognostic indices. Odds ra-
tio for hospitalization in the ICU, however, was incompa-
rably stronger, reaching a probability of death of 1,122.6%
higher than controls. The 2 sets of results are reproduced
in Table 4.
DISCUSSION
A single infectious disease may be the reason for the
demise of a previously healthy person. Microbial sequelae
that appear in the natural history of other diseases, as fre-
quently seen in hospitalized patients, contribute even more
frequently to the causes of therapeutic failure, especially
in intensive care units.5,10,13
Diagnostic uncertainty occurs, and inappropriate pre-
scription could result from wrong assumptions within dan-
gerous conditions. One noteworthy example is the disagree-
ment surrounding the concept of ventilator-associated pneu-
monia.28–30
A rise in inappropriate use of anti-infective drugs, in
parallel or not with controversies concerning diagnosis or
prognosis, is reported in some studies.31-33 In fact, there are
professionals who advocate the principle: “if in doubt, re-
inforce anti-infective drug therapy.”
The more critically ill subjects, presumably with more
demonstrated septic problems, were possibly those targeted
by associations, or sequential changes of anti-infective
medications. A slightly elevated death rate would thus be
a consequence of partial and incomplete relief of their sup-
posedly worse clinical condition, not of therapeutic mis-
use. If so, generous antimicrobial drug prescriptions should
be associated with more ICU admissions, but that percent-
age was not different from the control subjects in this study.
In the experience of Wilson et al34 with anaerobic
bacteremia, polymicrobial infection was one of the vari-
ables that was significantly associated with mortality in the
univariate analysis. Interestingly, multivariate testing did
not support this assumption, as only age (similarly to the
results of this study) along with liver disease were con-
firmed negative factors.
Inappropriate antibiotic administration, but not neces-
sarily of multiple agents, was a mechanism for increased
mortality in the series of community-acquired pneumonia
presented by Johnson et al.35 Adequate antibiotics were
highlighted as a weakly positive prognostic factor in the
large investigation of meningococcal disease by Barquet et
al,36 whereas age > 60 years was found to have markedly
ominous implications.
Multiple or consecutive introductions of anti-infective
drugs could be harmful by augmentation of side effects, or
by damage to defense systems via destruction of normal mi-
crobial flora, or by disruption of immunologic reactions.
Hecker et al,37 studying the redundant use of antibiot-
ics, found out that erroneous treatment of noninfectious
syndromes or nonbacterial entities was the second most fre-
quent explanation for 30% of hospital drug misuse, gener-
ating economic and clinical losses.
Substitution of skin or enteric microbial flora by resist-
ant bacteria or by fungi is a possibility, and potentially del-
eterious effects of antibiotics on the immunologic system,
although uncommon, have been reported. Tsimmerman and
Mikhaleva38 found an immunosuppressive action of antibi-
otics during treatment of Helicobacter pylori and duodenal
ulcer. Vesce et al39 identified inhibition of IL- 6 and pros-
Table 4 - Logistic regression variables of hospital mortality (All patients, n= 3706)
Description Beta coefficient SE* Significance  Odds ratio Confidence interval
Number of drugs 0.294 0.128 P < .02 1.341 1.043 – 1.725
Age 0.041 0.008 P < .01 1.042 1.026 – 1.058
ICU stay 2.418 0.267 P < .01 11.226 6.648 – 18.957
Anti-infective days 0.049 0.008 P < .01 1.050 1.033 – 1.067
Age 0.38 0.006 P < .01 1.039 1.027 – 1.051
ICU stay 2.025 0.190 P < .01 7.576 5.222 - 10.993
Obs: SE = Standard error
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taglandin E2 in amniotic fluid secondary to ampicilin intro-
duction. Stem cell mobilization can diminish during the use
of antibiotics acting on intestinal flora.40 In an inflammatory
bowel model, Colpaert et al41 described potentially undesir-
able cytokine-modulating effects of metronidazol.
Logistic regression analysis in the current circumstances
left little doubt that the anti-infective drug load, measured
by 2 different criteria, was a significant and independent
factor for hospital mortality. It must be emphasized that
the numerical weight of the anti-infective drug load was
somewhat greater than that of age (34.1% versus 4.2% in-
creased probability of mortality), but of the same order of
magnitude. In contrast, hospitalization in the ICU had by
far the strongest deleterious impact as assessed by odds ra-
tio: 1,122. 6% augmented risk. Similar findings corre-
sponded to days on anti-infective drug therapy, and all find-
ings were statistically significant.
Lack of stratification of patients according to primary
disease, severity score, classes of antibiotics, and interval
until death was a weakness in the design of this study.
These variables deserve additional studies.
CONCLUSIONS
It is concluded that: 1) A heavy load of anti-infective
drugs was associated with higher hospital mortality ac-
cording to both univariate and logistic regression analy-
sis; 2) The adverse influence was less marked than that
of hospitalization in ICU but of similar order of magni-
tude as age; 3) Further studies should elucidate whether
this results from serious infections per se despite appro-
priate drug utilization, or whether therapeutic misjudg-
ment in the form of unrecognized microbial foci, drug ef-
fects, or other noninfectious morbidity underlies this un-
desirable concurrence.
RESUMO
Spiandorello WP, Faintuch J, Ribeiro GT, Karkow FJ,
Alvares JO. Uso de múltiplos antimicrobianos por pacientes
clínicos. Um índice prognóstico de mortalidade hospitalar.
Clinics. 2006;61(1):15-20.
OBJETIVOS: Tendo como propósito quantificar o uso
múltiplo ou prolongado de antibióticos e quimioterápicos
antimicrobianos em pacientes clínicos, um estudo prospec-
tive foi executado em um hospital de 144 leitos.
MÉTODOS: Enfermos adultos tratados com antibióticos
e quimioterrápicos anti-infecciosos (2.790 pacientes com
3.706 internações) foram investigados. A duração da
hospitalização foi de 5,5 ± 6,7 dias (2 –226), sendo o prazo
de até 10 dias em 91,0% da população. A idade era de 57.4
±18.8 anos (20 –97), e 54.3% eram mulheres (2.012).
Antibióticos e outros agentes foram administrados a 1.166
indivíduos (31,5%); 325 (8,8%) necessitaram de assistência
na unidade de terapia intensiva, e no total 141 (3,8%)
faleceram.
RESULTADOS: A associação entre medicação anti-
infecciosa e mortalidade hospitalar foi estatisticamente
significativa (p< 0,01) com forte correlação linear (r=
0,902, p=0,014). A quantidade de antimicrobianos
prescritos, a idade e o requerimento de cuidados intensivos
foram variáveis independentes para óbito na regressão
logística. O cálculo do “odds ratio” para a medicação
analisada assinalava probabilidade de desfecho negativo de
1,341 (1,043 a 1,725) para múltiplos antimicrobianos, para
a idade de 1,042 (1,026 a 1,058), e para admissão na UTI
de 11,226 (6,648 a 18,957).
CONCLUSÕES: 1) O uso de grandes quantidades de
agentes antimicrobianos associou-se com mortalidade
hospitalar aumentada tanto pela análise univariada como
na regressão logística; 2) Seu efeito adverso foi menos
marcado que o associado à internação na unidade de
cuidados intensivos, porém de magnitude semelhante ao da
idade; 3) Estudos adicionais são necessários para elucidar
se este resultado indesejável se prende à ação de focos
infecciosos subjacentes, à morbidade não infecciosa ou aos
efeitos colaterais das drogas utilizadas,
UNITERMOS: Antibióticos. Quimioterapia anti-micro-
biana. Associação antibiótica. Múltiplos antibióticos.
Prognóstico hospitalar. Mortalidade hospitalar.
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